Novartis Campaign to Highlight Cosentyx’s Long-Term Benefits
Nearly a decade since its approval by the FDA for treating plaque psoriasis and psoriatic arthritis, Novartis is spotlighting the continued success of Cosentyx with the launch of its “Still
Comparing Humira and Stelara
Humira (adalimumab) and Stelara (ustekinumab) are biologic medications used to treat several chronic inflammatory conditions, including Crohn’s disease, ulcerative colitis, and plaque psoriasis. They work by targeting specific pathways in
Tirzepatide Lowers Weight Across All Groups With Obesity
The US Food and Drug Administration (FDA) granted fast-track status (expedited review) to tirzepatide for use as an anti-obesity drug.
How to Lower Your Risk of Kidney Failure and Heart Damage
Your heart and kidneys have a reciprocal relationship: Heart problems can hurt the kidneys, and kidney problems can damage the cardiovascular system. If you have heart or kidney disease, it’s
New Non-Statin Cholesterol Lowering Drugs: How to Use Them
This is important guidance. We now have two new US Food and Drug Administration (FDA)–approved cholesterol-lowering medicines over the past 2 years that our patients are seeing advertised on TV,
How Diet Alone Can Achieve Remission in Diabetes
Every year, roughly 1.4 million US adults are diagnosed with type 2 diabetes. But when doctors discuss treatment options with newly diagnosed patients, they often fail to include an intensive
Omega-3 Fatty Acids May Reduce Blood Pressure
An omega-3 fatty acid daily intake of approximately 3 grams, either in the form of supplements or food, may reduce blood pressure, a new meta-analysis suggests.
The findings showed a substantial